Key result
Hydroxyethyl starch was safe compared to albumin as a priming fluid for cardiopulmonary bypass, showing no significant difference in length of ICU stay or renal and coagulation function.
Why the study?
Hydroxyethyl starch has been widely used for volume expansion, but its safety as a priming fluid for cardiopulmonary bypass has been questioned recently.
Does hydroxyethyl starch improve safety compared to albumin as priming fluid for cardiopulmonary bypass in patients undergoing cardiac surgery?
Meta-Analysis (n=452)
Does hydroxyethyl starch improve safety compared to albumin as priming fluid for cardiopulmonary bypass in patients undergoing cardiac surgery?
Hydroxyethyl starch appears to be as safe as albumin when used as a priming fluid for cardiopulmonary bypass in cardiac surgery, without adversely affecting renal or coagulation function.
Answers are grounded in this paper and cite their sources.
Supports HES as alternative to albumin for CPB priming; confirms comparable safety profile in cardiac surgery.
Introduction: Hydroxyethyl starch (HES) has been widely used for volume expansion, but its safety as priming fluid for cardiopulmonary bypass has been questioned recently. The aim of this meta-analysis is to compare the safety of albumin and hydroxyethyl starch as priming fluid for cardiopulmonary bypass.Methods: Pubmed, Embase database and Cochrane Library were searched for randomized controlled trials (RCTs) involving patients who received HES or albumin as priming fluid for cardiopulmonary bypass in cardiac surgery published up to October 2019. Two reviewers independently extracted the valid data, including the length of ICU stay, ventilator time, the length of hospital stay, crystal volume, fresh frozen plasma, platelet input, blood loss, blood platelet count. hemoglobin value, fibrin, APTT, PT, urea, creatinine and urine volume. Meta-analysis was performed with revman version 5.3. Results: Total 9 RCTs involving 452 patients were included in this meta-analysis. Compared with albumin, HES had similar effects on the length of ICU stay(MD = 0.70;95%CI:-0.14 to 1.55;P = 0.10;I2 = 89%);ventilation time(MD = 2.31 ;95%CI-3.93 to 8.55;P = 0.47,I2 = 60%); the length of hospital stay(MD = -0.31;95% CI:-2.00 to 1.37; P = 0.71 ;I2 = 0%); crystal volume(SMD = 0.26;95% CI:-0.09 to 0.61; P = 0.15;I2 = 0%); fresh frozen plasma(SMD = 0.25;95%CI:-0.08 to 0.59;P = 0.66;I2 =0%); platelet input(SMD =-0.17;95% Cl:-0.59 to 0.26;P =0.45;I2 = 0%);blood loss (SMD =0.31;95% Cl:-0.01 to 0.63;P = 0.06;I2 =29%);platelet count (SMD =-0.21;95% cl :-0.54 to 0.11; P = 0.20;I2 = 29% );hemoglobin value(SMD =0.1;95% CI: -0.15 to 0.36;P = 0.42; I2 = 0% ); fibrin (SMD =0.12;95% CI: -0.19 to 0.44 ; P = 0.45; I2 = 0% );APTT(MD =1.13;95% CI: -2.06 to 4.32 ; P = 0.49; I2 = 0%);PT(MD =0.10;95% CI: -0.21 to 0.40,P = 0.52; I2 = 0%);creatinine(SMD =0.09;95% CI: -0.32 to 0.50 ; P = 0.66; I2 = 51% );urine volume(SMD =0.11;95% CI: -0.26 to 0.48 ; P = 0.55; I2 = 43% ).but did not increase urea (SMD =-0.46;95% CI: -0.81 to -0.11; P = 0.01; I2 = 0%).Conclusions: HES was safe and effective compared to albumin as priming fluid for cardiopulmonary bypass because it did not affect renal function, coagulation function, liquid input, or the length of ICU stay and ventilation time of patients.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2020) conducted a meta-analysis in Cardiac surgery requiring cardiopulmonary bypass (n=452). Hydroxyethyl starch vs. Albumin was evaluated on Length of ICU stay (MD 0.70, 95% CI -0.14 to 1.55, p=0.10). Hydroxyethyl starch was safe compared to albumin as a priming fluid for cardiopulmonary bypass, showing no significant difference in length of ICU stay or renal and coagulation function.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: